Cargando…
Mutagenesis after cancer therapy.
A subset of Hodgkin's disease (HD) and breast cancer patients have been reported to have elevated hprt mutant frequencies in peripheral blood lymphocytes after cessation of therapy. A subset of these patients are also known to develop second therapy-related malignancies. Therefore, it is clearl...
Autores principales: | Kelsey, K T, Caggana, M, Mauch, P M, Coleman, C N, Clark, J R, Liber, H L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1521128/ https://www.ncbi.nlm.nih.gov/pubmed/8143613 |
Ejemplares similares
-
The in vitro genetic effects of fibrous erionite and crocidolite asbestos.
por: Kelsey, K. T., et al.
Publicado: (1986) -
Cancer therapy – molecular targets in tumour–host interactions
por: Kurschat, P, et al.
Publicado: (2006) -
Mutagenesis testing program.
por: Valcovic, L R
Publicado: (1977) -
DNA Damage, Mutagenesis and Cancer
por: Basu, Ashis K.
Publicado: (2018) -
Complete cysteine-scanning mutagenesis of the Salmonella typhimurium melibiose permease
por: Markham, Kelsey J., et al.
Publicado: (2021)